Anlon Healthcare
add_icon

Anlon Healthcare

15.54
+0.05
(0.32%)
Market Cap
825.97 Cr
PE Ratio
25.85
Volume
8,66,351.00
Day High - Low
15.65 - 15.32
52W High-Low
17.28 - 9.08
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
825.97 Cr
EPS
6.11
PE Ratio
25.85
PB Ratio
3.58
Book Value
4.33
EBITDA
47.80
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
11.42
Debt to Equity
0.35
Forecast For
Actual

Company News

View All News
Caret
neutral
Anlon Healthcare Limited issued a corrigendum to its AGM notice to address exchange queries regarding its preferential share issue. The filing details the allotment of over 85.8 million shares at ₹17.85 each, raising approximately ₹1,533 crore.
positive
Anlon Healthcare Limited has filed its annual report for FY26, reporting a standalone revenue of ₹1,764.99 crore and net profit of ₹278.08 crore. The company seeks shareholder approval for the acquisition of Apiqo Organics and Bizotic Lifescience via share swap.
positive
Anlon Healthcare seeks AGM approval for share swaps to fully acquire Apiqo Organics and Bizotic Lifescience. The deal involves issuing 8.58 crore shares at ₹17.85 each, consolidating its pharmaceutical operations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,926.10
#1 4,62,135.91
36.66
#1 61,673.90
12.69
#1 11,565
26.53
50.68
9,226.00
2,44,921.31
81.66
11,067.00
13.95
2,568
65.50
69.96
4,981.50
1,89,480.25
84.54
13,886.20
20.34
2,138
3.28
51.80
1,154.80
1,16,199.90
23.78
27,657.90
17.64
5,026
-34.90
56.50
1,411.90
1,14,059.68
32.01
29,044.60
2.24
3,870
-39.18
46.47
1,831.90
98,896.33
91.90
6,867.80
22.01
890
#1 123.93
58.70
2,372.00
97,962.65
45.68
14,636.40
14.85
1,938
29.13
40.51
2,139.90
97,843.19
#1 16.51
29,038.90
#1 26.75
5,356
16.00
30.16
1,165.50
97,280.68
30.34
35,058.60
3.90
4,158
-69.10
44.37
1,690.40
97,261.88
25.61
34,145.20
5.56
3,503
25.21
61.10

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
42.90 %
Net Income Growth
41.95 %
Cash Flow Change
-169.12 %
ROE
-55.23 %
ROCE
-31.22 %
EBITDA Margin (Avg.)
3.20 %

Quarterly Financial Results

Quarterly Financials
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
49
33
52
36
51
88
Expenses
32
27
39
23
36
72
EBITDA
17
6
14
13
15
16
Operating Profit %
35 %
19 %
26 %
35 %
30 %
18 %
Depreciation
1
0
0
0
0
1
Interest
1
1
1
2
1
1
Profit Before Tax
16
5
12
11
14
14
Tax
-1
2
3
6
3
5
Net Profit
17
4
9
5
11
8
EPS in ₹
5.15
0.89
1.75
1.13
2.33
0.16

Balance Sheet

Balance Sheet
2025
2026
Total Assets
181
374
Fixed Assets
23
58
Current Assets
159
308
Capital Work in Progress
0
0
Investments
1
1
Other Assets
158
315
Total Equity & Liabilities
181
374
Current Liabilities
60
108
Non Current Liabilities
41
12
Total Equity
80
255
Reserve & Surplus
41
177
Share Capital
40
53

Cash Flow

Cash Flow
2025
2026
Net Cash Flow
-1
23
Investing Activities
2
-36
Operating Activities
-22
-59
Financing Activities
19
118

Share Holding

% Holding
Oct 2024
Apr 2025
Jun 2025
Aug 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
70.26 %
70.26 %
52.68 %
70.26 %
52.68 %
52.68 %
52.68 %
52.68 %
FIIs
0.00 %
0.00 %
14.42 %
0.00 %
0.00 %
0.23 %
0.32 %
1.67 %
DIIs
0.00 %
0.00 %
4.35 %
0.00 %
2.83 %
4.49 %
4.60 %
1.22 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.64 %
0.00 %
20.73 %
23.58 %
24.38 %
26.19 %
Others
29.74 %
29.74 %
13.92 %
29.74 %
23.75 %
19.02 %
18.02 %
18.24 %
No of Share Holders
109
131
9,125
135
9,126
11,412
12,484
34,671

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
05 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Sept 2026 14.47 15.51
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 13.91 14.25
09 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2026 12.12 12.61
24 Apr 2026 BONUS Bonus
1:1
24 Apr 2026 12.16 14.38
24 Apr 2026 SPLIT Split
2:10
24 Apr 2026 11.11 14.38
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 13.89 14.25
30 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2026 15.01 15.89

Announcements

Anlon Healthcare Limited Has Informed The Exchange Regarding Corrigendum To Notice Of Annual General Meeting To Be Held On September 05 20267 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 17, 2026
Reg. 34 (1) Annual Report.Aug 14, 2026
Notice Of 13Th Annual General Meeting Of Anlon Healthcare LimitedAug 14, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2026
Corporate Action - Fixes Book Closure For Annual General MeetingAug 13, 2026
Corporate Action Record Date Fixed For Annual General MeetingAug 13, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday August 13 2026Aug 13, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 13, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 12, 2026
Board Meeting Intimation for Rescheduled/Postponement Of MeetingAug 11, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 08, 2026
Closure of Trading WindowAug 06, 2026
Board Meeting Intimation for Approve Notice Of 13Th Annual General Meeting Of The CompanyAug 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 06, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2026
Financial Results For The Quarter Ended June 30 2026Jul 30, 2026
Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2026Jul 30, 2026
Board Meeting Intimation for Declaration Of Financial Results For The Quarter Ended June 30 2026Jul 27, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 20, 2026
Announcement For Incorporation Of Subsidiary CompanyJul 11, 2026
Announcement Of Incorporated Of Subsidiary Company Of Anlon Healthcare LimitedJul 09, 2026
Disclosure Regarding Interview/Podcast Of Chairman & Managing Director With Sumit Mehrotra Former Senior Anchor @CnbcawaazJul 06, 2026
Disclosure Regarding Interview Of Chairman & Managing Director With Money TVJul 01, 2026
Board Meeting Outcome for Incorporation Of Subsidiaries Of Anlon Healthcare LimitedJul 01, 2026
Closure of Trading WindowJun 30, 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Invitation For TV Interview On NDTV Profit.Jun 11, 2026
Intimation Regarding Media Interaction Of Chairman & Managing DirectorJun 09, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJun 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2026
Considered Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St March 2026May 29, 2026
Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 31 2026May 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
Board Meeting Intimation for To Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 Along With The Auditors Report Thereon.May 23, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2026
Updates On AcquisitionMay 08, 2026
Announcements Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 27, 2026
Announcement under Regulation 30 (LODR)-AllotmentApr 27, 2026
Intimation Of New ISINApr 22, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 16, 2026
Board Meeting Outcome for For Entered Into Share Purchase Agreement With Remember India Health Links Private LimitedApr 16, 2026
Announcement under Regulation 30 (LODR)-Credit RatingApr 15, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026

Technical Indicators

RSI(14)
Neutral
56.69
ATR(14)
Less Volatile
0.62
STOCH(9,6)
Neutral
65.27
STOCH RSI(14)
Overbought
88.45
MACD(12,26)
Bullish
0.16
ADX(14)
Weak Trend
24.76
UO(9)
Bearish
50.79
ROC(12)
Uptrend And Accelerating
7.35
WillR(14)
Neutral
-49.82